Diseases & Disorders
(G99)
IRS Verified
DX Registered
990 on File
OLIGO NATION
Financial strength (30%)
73/100
Reliability (20%)
50/100
Effectiveness (25%)
77/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Oligo Nation is the only nonprofit solely dedicated to accelerating a cure for oligodendroglioma, a rare and currently incurable form of brain cancer. Most living with Oligo are diagnosed in their 20s, 30s and early 40s, impacting individuals and their families in the prime of life. Oligo Nation funds critical research to find a cure and supports the 20,000+ Americans living with oligodendroglioma.
Financial Overview — FY 2025
N/A
Total Revenue
N/A
Total Expenses
N/A
Net Assets
5
Employees
Program Expense Ratio
N/A
Fundraising Efficiency
0.0%
Operating Reserve
N/A
Liability-to-Asset
0.0%
Revenue Diversification
N/A
Compared with Peers
FY 2023
Compared with 882 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
75.0% | 83.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
17.4% | 11.4% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
7.6% | 2.2% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
82.9% | 101.3% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
13.0 mo | 11.7 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
6.4% | 13.0% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
109.6% | 89.5% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
67.3% | 8.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
457.2% | 11.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-8.6% | 1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | N/A | N/A | N/A | — | 5 |
| 2023 | $1.6M | $1.8M | $1.9M | 75.0% | 2 |
| 2022 | $978K | $319K | $2.1M | 55.4% | 2 |
| 2021 | $673K | $556K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.